ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹104 Cr | ₹11 Cr | ₹-2.34 Cr | ₹14 Cr | ₹-30 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ERIS LIFESCIENCES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹-2.34 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹-30 Cr |
How is Net Cash Inflow / Outflow of ERIS LIFESCIENCES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 828.56 | |
| Mar2024 | ₹11 Cr | Positive | |
| Mar2023 | ₹-2.34 Cr | Negative | |
| Mar2022 | ₹14 Cr | Positive | |
| Mar2021 | ₹-30 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹20,850.2 Cr | 0.3% | -2% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 0.3% |
-2% |
9.1% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses